Adicet Bio Inc

Adicet Bio Inc

ACET

Market Cap$59.41M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Adicet Bio IncAdicet Bio Inc-0.6--73%-0.1
$0.45

Current Fair Value

42.6% downside

Overvalued by 42.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$59.41 Million
Enterprise Value$47.52 Million
Dividend Yield$0 (0%)
Earnings per Share$-1.33
Beta1.65
Outstanding Shares91,071,436

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-0.56
PEG-78.9
Price to Sales-
Price to Book Ratio0.78
Enterprise Value to Revenue-
Enterprise Value to EBIT-0.38
Enterprise Value to Net Income-1
Total Debt to Enterprise0.34
Debt to Equity0.1

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Adicet Bio, Inc.

152 employees
CEO: Mr. Chen Schor BA, CPA, M.B.A.

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell recepto...